OTC Drug Market Report

Europe OTC Drug Market Size, Status and Forecast 2014-2026

  • POSTDATE：Dec 21, 2019
  • PAGES：217
  • REPORT CODE：GMM406180
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The OTC Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.2% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe OTC Drug Market Segmentations:

    By Player:

    • GlaxoSmithKline (Sanofi)

    • Bukwang Pharmaceutica

    • DSM

    • Euradite

    • Taiji Group

    • Herbalife

    • Eisai

    • CoLucid

    • Bayer HealthCare

    • Pfizer

    • CR sanjiu

    • Friggs

    • Bristol Myers Squibb

    • GSK

    • Daiichi Sankyo

    • Don Ejiao

    • BioGaia

    • Chr. Hansen

    • Eli Lilly

    By Type:

    • Class A

    • Class B

    By End-User:

    • Hospital

    • Clinic

    • Household

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of OTC Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe OTC Drug Market Size and Growth Rate of Class A from 2014 to 2026

    • 1.3.2 Europe OTC Drug Market Size and Growth Rate of Class B from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe OTC Drug Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.2 Europe OTC Drug Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.4.3 Europe OTC Drug Market Size and Growth Rate of Household from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany OTC Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK OTC Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France OTC Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy OTC Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain OTC Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland OTC Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia OTC Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland OTC Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey OTC Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of OTC Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of OTC Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Class A

      • 3.4.2 Market Size and Growth Rate of Class B

    4 Segmentation of OTC Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of OTC Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of OTC Drug for Hospital

      • 4.4.2 Market Size and Growth Rate of OTC Drug for Clinic

      • 4.4.3 Market Size and Growth Rate of OTC Drug for Household

    5 Market Analysis by Major Regions

    • 5.1 Europe OTC Drug Production Analysis by Top Regions

    • 5.2 Europe OTC Drug Consumption Analysis by Top Regions

    • 5.3 Europe OTC Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany OTC Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 UK OTC Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 France OTC Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy OTC Drug Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain OTC Drug Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland OTC Drug Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia OTC Drug Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland OTC Drug Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey OTC Drug Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of OTC Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in OTC Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in OTC Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in OTC Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in OTC Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in OTC Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in OTC Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany OTC Drug Landscape Analysis

    • 7.1 Germany OTC Drug Landscape Analysis by Major Types

    • 7.2 Germany OTC Drug Landscape Analysis by Major End-Users

    8. UK OTC Drug Landscape Analysis

    • 8.1 UK OTC Drug Landscape Analysis by Major Types

    • 8.2 UK OTC Drug Landscape Analysis by Major End-Users

    9. France OTC Drug Landscape Analysis

    • 9.1 France OTC Drug Landscape Analysis by Major Types

    • 9.2 France OTC Drug Landscape Analysis by Major End-Users

    10. Italy OTC Drug Landscape Analysis

    • 10.1 Italy OTC Drug Landscape Analysis by Major Types

    • 10.2 Italy OTC Drug Landscape Analysis by Major End-Users

    11. Spain OTC Drug Landscape Analysis

    • 11.1 Spain OTC Drug Landscape Analysis by Major Types

    • 11.2 Spain OTC Drug Landscape Analysis by Major End-Users

    12. Poland OTC Drug Landscape Analysis

    • 12.1 Poland OTC Drug Landscape Analysis by Major Types

    • 12.2 Poland OTC Drug Landscape Analysis by Major End-Users

    13. Russia OTC Drug Landscape Analysis

    • 13.1 Russia OTC Drug Landscape Analysis by Major Types

    • 13.2 Russia OTC Drug Landscape Analysis by Major End-Users

    14. Switzerland OTC Drug Landscape Analysis

    • 14.1 Switzerland OTC Drug Landscape Analysis by Major Types

    • 14.2 Switzerland OTC Drug Landscape Analysis by Major End-Users

    15. Turkey OTC Drug Landscape Analysis

    • 15.1 Turkey OTC Drug Landscape Analysis by Major Types

    • 15.2 Turkey OTC Drug Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Landscape Analysis by Top Countries

      • 16.3.1 Denmark OTC Drug Market Volume and Growth Rate

      • 16.3.2 Finland OTC Drug Market Volume and Growth Rate

      • 16.3.3 Norway OTC Drug Market Volume and Growth Rate

      • 16.3.4 Sweden OTC Drug Market Volume and Growth Rate

      • 16.3.6 Iceland OTC Drug Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Landscape Analysis by Top Countries

      • 17.3.1 Belgium OTC Drug Market Volume and Growth Rate

      • 17.3.2 Netherlands OTC Drug Market Volume and Growth Rate

      • 17.3.3 Luxembourg OTC Drug Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Landscape Analysis by Top Countries

      • 18.3.1 Estonia OTC Drug Market Volume and Growth Rate

      • 18.3.2 Latvia OTC Drug Market Volume and Growth Rate

      • 18.3.3 Lithuania OTC Drug Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 GlaxoSmithKline (Sanofi)

      • 19.1.1 GlaxoSmithKline (Sanofi) Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Bukwang Pharmaceutica

      • 19.2.1 Bukwang Pharmaceutica Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 DSM

      • 19.3.1 DSM Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Euradite

      • 19.4.1 Euradite Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Taiji Group

      • 19.5.1 Taiji Group Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Herbalife

      • 19.6.1 Herbalife Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Eisai

      • 19.7.1 Eisai Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 CoLucid

      • 19.8.1 CoLucid Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Bayer HealthCare

      • 19.9.1 Bayer HealthCare Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Pfizer

      • 19.10.1 Pfizer Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 CR sanjiu

      • 19.11.1 CR sanjiu Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Friggs

      • 19.12.1 Friggs Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Bristol Myers Squibb

      • 19.13.1 Bristol Myers Squibb Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 GSK

      • 19.14.1 GSK Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Daiichi Sankyo

      • 19.15.1 Daiichi Sankyo Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Don Ejiao

      • 19.16.1 Don Ejiao Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 BioGaia

      • 19.17.1 BioGaia Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Chr. Hansen

      • 19.18.1 Chr. Hansen Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Eli Lilly

      • 19.19.1 Eli Lilly Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    The List of Tables and Figures (Totals 86 Figures and 121 Tables)

    • Figure Product Picture

    • Figure Europe OTC Drug Market Size and Growth Rate of Class A from 2014 to 2026

    • Figure Europe OTC Drug Market Size and Growth Rate of Class B from 2014 to 2026

    • Figure Europe OTC Drug Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Europe OTC Drug Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Europe OTC Drug Market Size and Growth Rate of Household from 2014 to 2026

    • Figure Germany OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Finland OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Norway OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania OTC Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of OTC Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of OTC Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of OTC Drug by Different Types from 2014 to 2026

    • Table Consumption Share of OTC Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Class A

    • Figure Market Size and Growth Rate of Class B

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of OTC Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of OTC Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Household

    • Table Europe OTC Drug Production by Major Regions

    • Table Europe OTC Drug Production Share by Major Regions

    • Figure Europe OTC Drug Production Share by Major Countries and Regions in 2014

    • Table Europe OTC Drug Consumption by Major Regions

    • Table Europe OTC Drug Consumption Share by Major Regions

    • Table Germany OTC Drug Production, Import, Consumption and Export Analysis

    • Table UK OTC Drug Production, Import, Consumption and Export Analysis

    • Table France OTC Drug Production, Import, Consumption and Export Analysis

    • Table Italy OTC Drug Production, Import, Consumption and Export Analysis

    • Table Spain OTC Drug Production, Import, Consumption and Export Analysis

    • Table Poland OTC Drug Production, Import, Consumption and Export Analysis

    • Table Russia OTC Drug Production, Import, Consumption and Export Analysis

    • Table Switzerland OTC Drug Production, Import, Consumption and Export Analysis

    • Table Turkey OTC Drug Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in OTC Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in OTC Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in OTC Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in OTC Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany OTC Drug Consumption by Types from 2014 to 2026

    • Table Germany OTC Drug Consumption Share by Types from 2014 to 2026

    • Table Germany OTC Drug Consumption by End-Users from 2014 to 2026

    • Table Germany OTC Drug Consumption Share by End-Users from 2014 to 2026

    • Table UK OTC Drug Consumption by Types from 2014 to 2026

    • Table UK OTC Drug Consumption Share by Types from 2014 to 2026

    • Table UK OTC Drug Consumption by End-Users from 2014 to 2026

    • Table UK OTC Drug Consumption Share by End-Users from 2014 to 2026

    • Table France OTC Drug Consumption by Types from 2014 to 2026

    • Table France OTC Drug Consumption Share by Types from 2014 to 2026

    • Table France OTC Drug Consumption by End-Users from 2014 to 2026

    • Table France OTC Drug Consumption Share by End-Users from 2014 to 2026

    • Table Italy OTC Drug Consumption by Types from 2014 to 2026

    • Table Italy OTC Drug Consumption Share by Types from 2014 to 2026

    • Table Italy OTC Drug Consumption by End-Users from 2014 to 2026

    • Table Italy OTC Drug Consumption Share by End-Users from 2014 to 2026

    • Table Spain OTC Drug Consumption by Types from 2014 to 2026

    • Table Spain OTC Drug Consumption Share by Types from 2014 to 2026

    • Table Spain OTC Drug Consumption by End-Users from 2014 to 2026

    • Table Spain OTC Drug Consumption Share by End-Users from 2014 to 2026

    • Table Poland OTC Drug Consumption by Types from 2014 to 2026

    • Table Poland OTC Drug Consumption Share by Types from 2014 to 2026

    • Table Poland OTC Drug Consumption by End-Users from 2014 to 2026

    • Table Poland OTC Drug Consumption Share by End-Users from 2014 to 2026

    • Table Russia OTC Drug Consumption by Types from 2014 to 2026

    • Table Russia OTC Drug Consumption Share by Types from 2014 to 2026

    • Table Russia OTC Drug Consumption by End-Users from 2014 to 2026

    • Table Russia OTC Drug Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland OTC Drug Consumption by Types from 2014 to 2026

    • Table Switzerland OTC Drug Consumption Share by Types from 2014 to 2026

    • Table Switzerland OTC Drug Consumption by End-Users from 2014 to 2026

    • Table Switzerland OTC Drug Consumption Share by End-Users from 2014 to 2026

    • Table Turkey OTC Drug Consumption by Types from 2014 to 2026

    • Table Turkey OTC Drug Consumption Share by Types from 2014 to 2026

    • Table Turkey OTC Drug Consumption by End-Users from 2014 to 2026

    • Table Turkey OTC Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) OTC Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark OTC Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland OTC Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway OTC Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden OTC Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland OTC Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) OTC Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium OTC Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands OTC Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg OTC Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) OTC Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia OTC Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia OTC Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries OTC Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of GlaxoSmithKline (Sanofi)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline (Sanofi)

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline (Sanofi)

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline (Sanofi)

    • Table Product and Service Introduction of GlaxoSmithKline (Sanofi)

    • Table Company Profile and Development Status of Bukwang Pharmaceutica

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bukwang Pharmaceutica

    • Figure Sales and Growth Rate Analysis of Bukwang Pharmaceutica

    • Figure Revenue and Market Share Analysis of Bukwang Pharmaceutica

    • Table Product and Service Introduction of Bukwang Pharmaceutica

    • Table Company Profile and Development Status of DSM

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DSM

    • Figure Sales and Growth Rate Analysis of DSM

    • Figure Revenue and Market Share Analysis of DSM

    • Table Product and Service Introduction of DSM

    • Table Company Profile and Development Status of Euradite

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Euradite

    • Figure Sales and Growth Rate Analysis of Euradite

    • Figure Revenue and Market Share Analysis of Euradite

    • Table Product and Service Introduction of Euradite

    • Table Company Profile and Development Status of Taiji Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Taiji Group

    • Figure Sales and Growth Rate Analysis of Taiji Group

    • Figure Revenue and Market Share Analysis of Taiji Group

    • Table Product and Service Introduction of Taiji Group

    • Table Company Profile and Development Status of Herbalife

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Herbalife

    • Figure Sales and Growth Rate Analysis of Herbalife

    • Figure Revenue and Market Share Analysis of Herbalife

    • Table Product and Service Introduction of Herbalife

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

    • Table Company Profile and Development Status of CoLucid

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CoLucid

    • Figure Sales and Growth Rate Analysis of CoLucid

    • Figure Revenue and Market Share Analysis of CoLucid

    • Table Product and Service Introduction of CoLucid

    • Table Company Profile and Development Status of Bayer HealthCare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer HealthCare

    • Figure Sales and Growth Rate Analysis of Bayer HealthCare

    • Figure Revenue and Market Share Analysis of Bayer HealthCare

    • Table Product and Service Introduction of Bayer HealthCare

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of CR sanjiu

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CR sanjiu

    • Figure Sales and Growth Rate Analysis of CR sanjiu

    • Figure Revenue and Market Share Analysis of CR sanjiu

    • Table Product and Service Introduction of CR sanjiu

    • Table Company Profile and Development Status of Friggs

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Friggs

    • Figure Sales and Growth Rate Analysis of Friggs

    • Figure Revenue and Market Share Analysis of Friggs

    • Table Product and Service Introduction of Friggs

    • Table Company Profile and Development Status of Bristol Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol Myers Squibb

    • Table Product and Service Introduction of Bristol Myers Squibb

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Daiichi Sankyo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo

    • Table Product and Service Introduction of Daiichi Sankyo

    • Table Company Profile and Development Status of Don Ejiao

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Don Ejiao

    • Figure Sales and Growth Rate Analysis of Don Ejiao

    • Figure Revenue and Market Share Analysis of Don Ejiao

    • Table Product and Service Introduction of Don Ejiao

    • Table Company Profile and Development Status of BioGaia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioGaia

    • Figure Sales and Growth Rate Analysis of BioGaia

    • Figure Revenue and Market Share Analysis of BioGaia

    • Table Product and Service Introduction of BioGaia

    • Table Company Profile and Development Status of Chr. Hansen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chr. Hansen

    • Figure Sales and Growth Rate Analysis of Chr. Hansen

    • Figure Revenue and Market Share Analysis of Chr. Hansen

    • Table Product and Service Introduction of Chr. Hansen

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US